Accessibility Menu
VanEck ETF Trust - VanEck Pharmaceutical ETF logo

VanEck ETF Trust - VanEck Pharmaceutical ETF(NASDAQ) PPH

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+313%
5 Year+63%
1 Year+27%
1 Month+2%
$111.31
+0.61%
+0.68Today
VanEck ETF Trust - VanEck Pharmaceutical ETF last closing stock price
MetricPriceDate
Last closeUSD 111.312026-07-27
VanEck ETF Trust - VanEck Pharmaceutical ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.15%USD 107.912026-07-20
1 month+2.29%USD 108.812026-06-26
3 month+12.25%USD 99.162026-04-28
Year to date+9.4%USD 101.752025-12-31
1 year+26.8%USD 87.792025-07-25
3 year+46.99%USD 75.722023-07-28
5 year+63.14%USD 68.232021-07-28
Since inception+313.18%USD 26.782011-12-21

VanEck ETF Trust - VanEck Pharmaceutical ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$2.17

Beta (Volatility)

0.47 (Low)

Price

$111.31

Volume

201,293.728

Open

$111.35

Previous Close

$111.31

Daily Range

$110.57 - $112.19

52-Week Range

$81.74 - $112.58

Estimated Earnings Date

N/A

PPH News

ETFvsETF-Purple.png

Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?

Brendan CoffeyJul 26, 2026
ETFvsETF-Green.png

Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ

Eric TrieJul 22, 2026
ETFvsETF-Red.png

For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?

Brendan CoffeyJul 20, 2026
ETFvsETF-Green.png

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

Erin KennedyJul 9, 2026
ETFvsETF-Blue.png

Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?

Robert IzquierdoJul 4, 2026
ETFvsETF-Purple.png

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy?

Josh Kohn-LindquistJun 18, 2026
ETFvsETF-Purple.png

Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.

Sarah SidlowJun 2, 2026
ETFvsETF-Green.png

PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem

Sara AppinoMay 27, 2026
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About VanEck ETF Trust - VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF focuses on replicating the performance of the MVIS US Listed Pharmaceutical 25 Index. This ETF targets companies involved in pharmaceutical research, development, production, marketing, and sales.

Products and Services
  • Tracks the MVIS US Listed Pharmaceutical 25 Index
  • Invests in pharmaceutical companies across various sectors
  • Offers exposure to the pharmaceutical industry's growth potential
Growth Outlook
  • Pharmaceutical sector projected to grow significantly in the coming years
  • Increased global healthcare spending supports industry expansion
  • Innovation in drug development drives long-term growth potential
Financial Highlights
  • Market capitalization of approximately $649.8 million
  • Recent dividend yield of 1.97% reflects steady income potential
  • Stock price range over the past year: $81.74 to $112.58
The VanEck Pharmaceutical ETF provides investors with a focused approach to the pharmaceutical sector, capitalizing on the industry's growth and innovation. With a solid market capitalization and a competitive dividend yield, this ETF represents a strategic option for those interested in the pharmaceutical landscape. The ongoing advancements in drug development and increasing healthcare expenditures further enhance the attractiveness of this investment vehicle.
AI Generated • Jul 20, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

New York, NY 10017, US

PPH Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

1.96%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.69M

Volume

201.29K

Avg. Volume

240.39K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

VanEck ETF Trust - VanEck Pharmaceutical ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CXSEWisdomTree China ex-State-Owned Enterprises Fund
$38.13+1.71%
EBILongview Advantage ETF
$65.48+0.02%
BBHVanEck Biotech ETF
$204.07+0.25%
FYCFirst Trust Small Cap Growth AlphaDEX Fund
$118.96+0.87%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%

Questions About PPH

What is the current price of VanEck ETF Trust - VanEck Pharmaceutical ETF?

VanEck ETF Trust - VanEck Pharmaceutical ETF is trading at $111.31 per share.

What is the 52-week range for VanEck ETF Trust - VanEck Pharmaceutical ETF?

Over the past 52 weeks, VanEck ETF Trust - VanEck Pharmaceutical ETF has traded between $81.74 and $112.58.

How much debt does VanEck ETF Trust - VanEck Pharmaceutical ETF have?

VanEck ETF Trust - VanEck Pharmaceutical ETF total debt is unavailable.

How much cash does VanEck ETF Trust - VanEck Pharmaceutical ETF have on hand?

VanEck ETF Trust - VanEck Pharmaceutical ETF does not have cash on hand data available.

What is VanEck ETF Trust - VanEck Pharmaceutical ETF’s dividend yield?

VanEck ETF Trust - VanEck Pharmaceutical ETF currently has a dividend yield of 1.96%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services